Q0235
HCPCSInj, monoclon antibody, 1 mg
Official HCPCS Level II long descriptor
Injection, monoclonal antibody products with an indication for post-exposure prophylaxis or treatment of covid-19, for hospitalized adults and/or pediatric patients who are receiving systemic corticosteroids and require supplemental oxygen, non-invasive or invasive mechanical ventilation, or extracorporeal membrane oxygenation (ecmo) only, not otherwise classified, 1 mg
HCPCS Level II code Q0235 is maintained by CMS and is active in the current quarterly release.
Short descriptor
Inj, monoclon antibody, 1 mg
Added to HCPCS: 2025-10-01
Nearby codes in Q0
- Q0169Promethazine hcl 12.5mg oral
- Q0173Trimethobenzamide hcl 250mg
- Q0175Perphenazine 4mg oral
- Q0177Hydroxyzine pamoate 25mg
- Q0180Dolasetron mesylate oral
- Q0181Unspecified oral anti-emetic
- Q0224Inj, pemivibart, 4500 mg
- Q0234Inj, tocilizumab-bavi, 1mg
- Q0237Inj, tocilizumab-anoh, hospi
- Q0238Inj, tocilizumab-aazg, hospi
- Q0249Tocilizumab for covid-19
- Q0477Pwr module pt cable lvad rpl
- Q0478Power adapter, combo vad
- Q0479Power module combo vad, rep
- Q0480Driver pneumatic vad, rep
- Q0481Microprcsr cu elec vad, rep
Where this code sits
Krasyn Codes for Chrome
Review coding suggestions beside a validated web workflow. Private pilot.
Request pilot accessSource
HCPCS Level II July 2026 quarterly update. Centers for Medicare & Medicaid Services (CMS), “July 2026 Alpha-Numeric HCPCS File” (HCPC2026_JUL_ANWEB_06172026.txt). Download the original file from cms.gov. Public domain (US Government work). Descriptors, billable flags and instructional notes on this page are reproduced from that file without modification. Krasyn adds no clinical guidance.